DOXAZOSIN

Generic: DOXAZOSIN, DOXAZOSIN MESYLATE

Mylan Pharmaceuticals Inc.Manufacturer
ORALRoute
DOXAZOSIN MESYLATEActive Substance
1990-11-02Original Approval

DOXAZOSIN is FDA application NDA019668, sponsored by VIATRIS. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.

Recalls

Class III2026-01-21
Doxazosin Tablets, USP, 4 mg, 1000 tablets per bottle, Rx only, distributed by Unichem Pharmaceuticals (USA), Inc., 1 To

Tablets/Capsules Imprinted with Wrong ID

Top Reported Reactions

1
DYSPNOEA
532 reports
2
FATIGUE
438 reports
3
DIARRHOEA
408 reports
4
DIZZINESS
376 reports
5
ASTHMA
348 reports
6
CONDITION AGGRAVATED
330 reports
7
DRUG INEFFECTIVE
314 reports
8
NAUSEA
302 reports
9
HYPOTENSION
299 reports
10
PRODUCTIVE COUGH
297 reports